[
  {
    "sentence": "Exosomes from the supernatants of MDA-MB-231 cells with or without circSIPA1L3 overexpression were isolated via ultracentrifugation, which exhibited similar typical membrane structure and size distribution as observed by transmission electron microscope (TEM) and nanoparticle tracker analysis (NTA) (Fig. 3a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The expression of exosome marker proteins was detected by western blot (Fig. 3c), validating the successful isolation of exosomes from breast cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, we found that the expression of circSIPA1L3 was decreased in cells treated with GW4869 (Fig. 3d), a noncompetitive inhibitor of neutral sphingomyelinase (N-SMase) which inhibits exosome formation [27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the circSIPA1L3 expression in exosomes was increased in breast cancer cells with circSIPA1L3 overexpression, whereas circSIPA1L3 knockdown led to opposite results (Fig. 3e).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "To validate that exosomal circSIPA1L3 could be taken up by receptor cells, PKH26 staining was conducted and fluorescent-labeled exosomes were observed in the receptor cells (Fig. 3f).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The circSIPA1L3 expression was increased in MDA-MB-231 cells that treated with exosomes highly expressing circSIPA1L3 than in control group (Fig. 3g).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel g",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel g",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel g",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, we validated that circSIPA1L3-exosomes significantly enhanced the proliferation, migration, invasion, and stemness of MDA-MB-231 cells compared with the control group (Fig. 3h, i).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel h",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Most noteworthy, the lactate secretion and ATP production of MDA-MB-231 were evidently elevated after treated with breast cancer cell-derived exosomes, especially in the circSIPA1L3 overexpression group (Fig. 3j), which indicated the role of exosomal circSIPA1L3 as an essential glycolysis regulator during breast cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel j",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel j",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel j",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, GW4869 treatment led to obviously attenuated malignant behaviors of MDA-MB-231 cells caused by circSIPA1L3-overexpressing exosomes (Fig. 3k, l).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel k",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "In xenograft tumors treated with circSIPA1L3-exosomes, obviously increased tumor volume and tumor weight were also observed (Fig. 3m, n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel m",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Exosomes from the supernatants of MDA-MB-231 cells with or without circSIPA1L3 overexpression were isolated via ultracentrifugation, which exhibited similar typical membrane structure and size distribution as observed by transmission electron microscope (TEM) and nanoparticle tracker analysis (NTA) (Fig. 3a, b).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The expression of exosome marker proteins was detected by western blot (Fig. 3c), validating the successful isolation of exosomes from breast cancer cells.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Furthermore, we found that the expression of circSIPA1L3 was decreased in cells treated with GW4869 (Fig. 3d), a noncompetitive inhibitor of neutral sphingomyelinase (N-SMase) which inhibits exosome formation [27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, the circSIPA1L3 expression in exosomes was increased in breast cancer cells with circSIPA1L3 overexpression, whereas circSIPA1L3 knockdown led to opposite results (Fig. 3e).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "To validate that exosomal circSIPA1L3 could be taken up by receptor cells, PKH26 staining was conducted and fluorescent-labeled exosomes were observed in the receptor cells (Fig. 3f).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The circSIPA1L3 expression was increased in MDA-MB-231 cells that treated with exosomes highly expressing circSIPA1L3 than in control group (Fig. 3g).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel g",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel g",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel g",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Moreover, we validated that circSIPA1L3-exosomes significantly enhanced the proliferation, migration, invasion, and stemness of MDA-MB-231 cells compared with the control group (Fig. 3h, i).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel h",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Most noteworthy, the lactate secretion and ATP production of MDA-MB-231 were evidently elevated after treated with breast cancer cell-derived exosomes, especially in the circSIPA1L3 overexpression group (Fig. 3j), which indicated the role of exosomal circSIPA1L3 as an essential glycolysis regulator during breast cancer development.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel j",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel j",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel j",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, GW4869 treatment led to obviously attenuated malignant behaviors of MDA-MB-231 cells caused by circSIPA1L3-overexpressing exosomes (Fig. 3k, l).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel k",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "In xenograft tumors treated with circSIPA1L3-exosomes, obviously increased tumor volume and tumor weight were also observed (Fig. 3m, n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel m",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We found that the circSIPA1L3 expression was significantly elevated in breast cancer tissue compared with normal samples (Fig. 7a, b), and higher circSIPA1L3 expression was associated with ER, PR, and distant metastasis status (Table S1).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Consistently, the elevated expression of circSIPA1L3 was detected in TNBC tissues compared to non-TNBC tissues (Fig. 7c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel c",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel c",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel c",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Kaplan–Meier analysis revealed that the higher circSIPA1L3 expression was correlated with poor prognosis of breast cancer patients as well as TNBC patients (Fig. 7d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel d",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Notably, we also found elevated circSIPA1L3 expression in the serum of breast cancer patients compared with healthy donors, and the ROC (receiver operating characteristic) curve analysis showed an AUC value of 0.72 (Fig. 7f), indicating the high sensitivity and specificity of circSIPA1L3 as a diagnostic biomarker for breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Together, our results comprehensively demonstrated the essential role and regulatory mechanism of circSIPA1L in breast cancer glycolysis and progression (Fig. 7g).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel g",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel g",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel g",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "We found that the circSIPA1L3 expression was significantly elevated in breast cancer tissue compared with normal samples (Fig. 7a, b), and higher circSIPA1L3 expression was associated with ER, PR, and distant metastasis status (Table S1).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel a",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Consistently, the elevated expression of circSIPA1L3 was detected in TNBC tissues compared to non-TNBC tissues (Fig. 7c).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel c",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel c",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel c",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Kaplan–Meier analysis revealed that the higher circSIPA1L3 expression was correlated with poor prognosis of breast cancer patients as well as TNBC patients (Fig. 7d, e).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel d",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Notably, we also found elevated circSIPA1L3 expression in the serum of breast cancer patients compared with healthy donors, and the ROC (receiver operating characteristic) curve analysis showed an AUC value of 0.72 (Fig. 7f), indicating the high sensitivity and specificity of circSIPA1L3 as a diagnostic biomarker for breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel f",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Together, our results comprehensively demonstrated the essential role and regulatory mechanism of circSIPA1L in breast cancer glycolysis and progression (Fig. 7g).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel g",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel g",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel g",
        "figure_key": "figure_7"
      }
    ]
  }
]